Addex Therapeutics Ltd. — All Filings
252 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
CERT
CORRESP
D
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
NT 20-F
POS AM
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K/A | FORM 6-K/A | 0001104659-23-127862 | Dec 21, 2023 | Jun 30, 2023 |
| 6-K | FORM 6-K | 0001171843-23-007632 | Dec 20, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-007563 | Dec 14, 2023 | — |
| SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) | 0001072613-23-000611 | Dec 8, 2023 | — |
| 424B3 | 424B3 | 0001104659-23-122406 | Nov 30, 2023 | — |
| EFFECT | — | 9999999995-23-003479 | Nov 29, 2023 | — |
| POS AM | POS AM | 0001104659-23-121793 | Nov 29, 2023 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-122019 | Nov 29, 2023 | — |
| 6-K | FORM 6-K | 0001104659-23-121737 | Nov 29, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-007294 | Nov 28, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-007060 | Nov 14, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-006845 | Nov 8, 2023 | — |
| 424B3 | 424B3 | 0001104659-23-110607 | Oct 23, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-006324 | Oct 20, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-006132 | Oct 6, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-005796 | Sep 20, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-005540 | Sep 5, 2023 | Sep 4, 2023 |
| 6-K | FORM 6-K | 0001171843-23-005543 | Sep 5, 2023 | — |
| 424B3 | 424B3 | 0001104659-23-090450 | Aug 11, 2023 | — |
| EFFECT | — | 9999999995-23-002338 | Aug 10, 2023 | — |
| 6-K | FORM 6-K | 0001104659-23-089501 | Aug 10, 2023 | — |
| POS AM | POS AM | 0001104659-23-089769 | Aug 10, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-004937 | Aug 3, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-004600 | Jul 24, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-003938 | Jun 15, 2023 | — |
| S-8 | FORM S-8 | 0001104659-23-069380 | Jun 8, 2023 | — |
| EFFECT | — | 9999999995-23-001619 | Jun 2, 2023 | — |
| 424B3 | 424B3 | 0001104659-23-067594 | Jun 2, 2023 | — |
| CORRESP | — | 0001104659-23-067025 | Jun 1, 2023 | — |
| F-1/A | FORM F-1/A | 0001104659-23-067020 | Jun 1, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-003680 | Jun 1, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-003402 | May 18, 2023 | — |
| CORRESP | — | 0001104659-23-059720 | May 12, 2023 | — |
| CORRESP | — | 0001104659-23-059144 | May 11, 2023 | — |
| F-1/A | F-1/A | 0001104659-23-059096 | May 11, 2023 | — |
| 6-K | FORM 6-K | 0001104659-23-058681 | May 11, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-003121 | May 10, 2023 | — |
| UPLOAD | — | 0000000000-23-004854 | May 9, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-002923 | May 5, 2023 | — |
| F-1 | F-1 | 0001104659-23-055487 | May 3, 2023 | — |
| D | — | 0001231919-23-000017 | Apr 13, 2023 | — |
| SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) | 0001072613-23-000298 | Apr 10, 2023 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-042133 | Apr 5, 2023 | — |
| 424B5 | 424B5 | 0001104659-23-041624 | Apr 4, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-002102 | Apr 4, 2023 | — |
| 6-K | FORM 6-K | 0001104659-23-041530 | Apr 4, 2023 | — |
| 6-K | FORM 6-K | 0001171843-23-002052 | Apr 3, 2023 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-040143 | Mar 31, 2023 | — |
| 20-F | FORM 20-F | 0001104659-23-038581 | Mar 30, 2023 | Dec 31, 2022 |
| 6-K | FORM 6-K | 0001171843-23-001991 | Mar 30, 2023 | — |